Robotic Balance Training + Brain Stimulation for Traumatic Brain Injury
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that participants should not plan to change their medication in the next four months.
What data supports the effectiveness of the treatment NEUROBALANCE Training for traumatic brain injury?
Research shows that combining physical therapy with brain stimulation can help improve balance and movement in people with traumatic brain injury. For example, a study found that using a balance training program with visual cues improved balance and stability in participants with TBI. This suggests that similar approaches, like NEUROBALANCE Training, might also be effective.12345
Is Robotic Balance Training + Brain Stimulation safe for humans?
The research articles provided do not directly address the safety of Robotic Balance Training + Brain Stimulation for traumatic brain injury, but they do explore related therapies like virtual reality and treadmill training, vestibular rehabilitation, and translingual neurostimulation, which are generally considered safe in humans.13467
How is the NEUROBALANCE Training treatment different from other treatments for traumatic brain injury?
NEUROBALANCE Training is unique because it combines robotic balance training with brain stimulation to specifically target and improve balance mechanisms that are often impaired in individuals with traumatic brain injury. This approach is different from traditional therapies as it focuses on enhancing both anticipatory and compensatory postural responses, which are crucial for maintaining balance.358910
What is the purpose of this trial?
Our proposed study, \"NEUROBALANCE,\" aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance functions in individuals with chronic traumatic brain injury (TBI). The study will recruit 45 participants who have had a TBI for over six months and experience persistent balance deficits. Participants will be randomized into three groups: (1) robotic balance training with active brain stimulation, (2) robotic balance training with sham brain stimulation, and (3) standard-of-care rehabilitation.The study will involve 12 training sessions over four weeks, with assessments conducted at baseline, post-training, and two months post-training to evaluate balance recovery and retention. The primary focus is understanding how this intervention affects brain and muscle activity during balance tasks and how these changes translate into functional improvements in clinical outcome measures of balance function. Additionally, participant feedback on brain stimulation and exercise engagement will be collected to inform future studies.This research is particularly relevant to military service members, as TBI and balance impairments are common among this population. The findings may guide the development of personalized training protocols and contribute to broader rehabilitation strategies.
Research Team
Vikram Shenoy Handiru, Ph.D.
Principal Investigator
Kessler Foundation
Eligibility Criteria
This trial is for individuals aged 18-75 who have had a non-penetrating traumatic brain injury (TBI) at least six months ago and are experiencing balance issues. They must be able to stand with or without support, walk at least ten meters, not change medications soon, and understand instructions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 12 sessions of robotic balance training with either active or sham brain stimulation over four weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments conducted at baseline, post-training, and two months post-training
Treatment Details
Interventions
- NEUROBALANCE Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kessler Foundation
Lead Sponsor
United States Department of Defense
Collaborator